Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CCXI

ChemoCentryx (CCXI) Stock Price, News & Analysis

ChemoCentryx logo

About ChemoCentryx Stock (NASDAQ:CCXI)

Advanced Chart

Key Stats

Today's Range
$51.99
$51.99
50-Day Range
$51.66
$51.99
52-Week Range
$14.95
$52.00
Volume
113 shs
Average Volume
1.68 million shs
Market Capitalization
$3.71 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CCXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ChemoCentryx and its competitors with MarketBeat's FREE daily newsletter.

CCXI Stock News Headlines

Rishi Gupta's Net Worth
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
See More Headlines

CCXI Stock Analysis - Frequently Asked Questions

ChemoCentryx, Inc. (NASDAQ:CCXI) released its earnings results on Monday, November, 8th. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.13. The biopharmaceutical company had revenue of $17.74 million for the quarter, compared to the consensus estimate of $14.70 million. ChemoCentryx had a negative trailing twelve-month return on equity of 48.52% and a negative net margin of 357.01%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ChemoCentryx investors own include Energy Transfer (ET), Gilead Sciences (GILD), Exelixis (EXEL), Meta Platforms (META), HubSpot (HUBS) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2021
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CCXI
CIK
1340652
Employees
178
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$131.76 million
Net Margins
-357.01%
Pretax Margin
-357.01%
Return on Equity
-48.52%
Return on Assets
-30.59%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
4.54
Quick Ratio
4.47

Sales & Book Value

Annual Sales
$32.22 million
Price / Sales
115.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.09 per share
Price / Book
12.71

Miscellaneous

Outstanding Shares
71,356,000
Free Float
65,433,000
Market Cap
$3.71 billion
Optionable
Optionable
Beta
1.22

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:CCXI) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners